A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77
Xi Chen(Tongji University), Hongtao Zhang(Chinese Academy of Sciences), Hang Ruan(University of Pennsylvania), Mark I. Greene(University of Pennsylvania), Donna M. Peehl(City College of San Francisco), Yasuhiro Nagai(University of Pennsylvania), Zhiqiang Zhu(University of Science and Technology of China)
Cited by 12
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271